Company Filing History:
Years Active: 2023
Title: Elodie Chabrol: Innovator in Genetic Engineering
Introduction
Elodie Chabrol is a prominent inventor based in London, GB. She has made significant contributions to the field of genetic engineering, particularly in the development of expression vectors that can be utilized in medical treatments.
Latest Patents
Chabrol holds a patent for "Expression vectors comprising engineered genes." This invention provides expression vectors, nucleic acids, vector particles, and methods of treatment involving these vector particles. The patent specifically focuses on an engineered KCNA1 gene that encodes an edited Kv1.1 potassium channel. The features of the engineered KCNA1 gene enhance the translation and activity of the Kv1.1 protein, improving the detection of KCNA1 gene expression in cells. This innovation has potential applications in the treatment of epilepsy and similar neurological disorders.
Career Highlights
Elodie Chabrol is associated with UCL Business Plc, where she continues to advance her research and innovations. Her work has garnered attention for its potential impact on medical science and treatment methodologies.
Collaborations
Chabrol collaborates with notable colleagues, including Stephanie Schorge and Matthew Charles Walker. Their combined expertise contributes to the advancement of research in genetic engineering and its applications.
Conclusion
Elodie Chabrol is a trailblazer in the field of genetic engineering, with her innovative patent paving the way for new treatments for neurological disorders. Her contributions are significant and continue to influence the scientific community.